Mani Arumugam is a Group Leader and Associate Professor at the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen. He leads the “Microbiome Systems Biology” research group that investigates how health and diseases are influenced by our gut microbiome; how the gut microbiome interacts with the host and environmental factors; and how we can therapeutically modulate the gut microbiome to improve health. His group takes interdisciplinary approaches combining multi-omics microbiome data to study host-microbial cross-talk. The group also investigates therapeutic approaches to modulate the gut microbiome towards improving human health.
Mani has been studying the human microbiome for over 14 years, with a broad scope investigating the role of gut microbiome in multiple sclerosis, obesity, liver disease, ageing and antimicrobial peptides. He currently leads Work Packages for microbiome multi-omics data integration in two large EU Horizon 2020 consortia (GALAXY and MICROB-PREDICT) studying liver diseases. He was listed among the Highly Cited Researchers of 2018, 2019 and 2020 by Clarivate Analytics.